Shanghai Ark Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Ark Biopharmaceutical Co., Ltd., explained in plain language.
-
Cream could stop raised scars from growing back after removal
Disease control CompletedThis study tests whether AK3280 cream can prevent hypertrophic scars from coming back after they are surgically removed. About 30 adults with raised scars (not on the face or upper neck) will receive either the active cream or a placebo on different parts of the scar. Researchers…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New ADHD pill for kids shows promise in Late-Stage trial
Disease control CompletedThis study tests an oral capsule called AK0901 (AZSTARYS) in children aged 6 to 12 with attention deficit hyperactivity disorder (ADHD). The trial compares the drug against a placebo to see if it reduces ADHD symptoms like inattention and hyperactivity. Researchers measure sympto…
Phase: PHASE3 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Heart check: experimental drug ziresovir put to the test in healthy adults
Knowledge-focused CompletedThis completed Phase 1 trial tested whether the experimental drug ziresovir affects the heart's electrical activity in 34 healthy adults. Participants received different doses of ziresovir, a placebo, and an active control (moxifloxacin) to compare effects. The main goal was to m…
Phase: PHASE1 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC